🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was to assess whether sofosbuvir in combination with ribavirin (...
Status
Completed
Location
University of Alabama Birmingham
Start Date
2012-06
Trial ID
NCT01641640
Treatments Being Tested
The study will begin with a two-week lead-in period (W-2 and W-1), when par...
Status
Recruiting
Location
RDSS Research Center
Start Date
2023-07-20
Trial ID
NCT06676410
Treatments Being Tested
This is a phase 2 study to evaluate the safety and tolerability of combinat...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2021-05-01
Trial ID
NCT04819347
Treatments Being Tested
The current study is a prospective, randomized, open, multi-center investig...
Status
Unknown
Location
Xixi Hospital of Hangzhou
Start Date
2016-11
Trial ID
NCT03013556
Immunoprophylaxis with two hepatitis B vaccinations following the hepatitis...
Status
Unknown
Location
Beijing Youan Hospital, Capital Medical University
Start Date
2018-06-10
Trial ID
NCT03476083
Treatments Being Tested
New outpatient treatments for COVID-19 are urgently needed. There is some e...
Status
Terminated
Location
Robert Wood Johnson Medical School
Start Date
2020-12-02
Trial ID
NCT04605588
This study tests a new nasal spray for adults (18-65 years) with chronic si...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-01
Trial ID
NCT07635459
To evaluate the safety and determine the pharmacokinetic disposition of sta...
Status
Completed
Location
Harbor - UCLA Med. Ctr. - Dept. of Peds., Div. of Infectious Diseases
Start Date
TBD
Trial ID
NCT00000851
Treatments Being Tested
This phase 2b study will evaluate the efficacy and safety of 16 and 24 week...
Status
Completed
Location
Mayo Clinic
Start Date
2010-10
Trial ID
NCT01225380
The primary objectives of this study are to evaluate the efficacy, safety, ...
Status
Completed
Location
National Cancer Institute, Cairo University
Start Date
2016-08-28
Trial ID
NCT02868242
Treatments Being Tested